E8X Stock Overview
Develops, produces, and sells dental lasers for soft and hard tissue applications primarily in Germany. More details
| Snowflake Score | |
|---|---|
| Valuation | 0/6 |
| Future Growth | 0/6 |
| Past Performance | 0/6 |
| Financial Health | 0/6 |
| Dividends | 0/6 |
elexxion AG Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | €0.27 |
| 52 Week High | €1.28 |
| 52 Week Low | €0.0005 |
| Beta | 0 |
| 11 Month Change | -17.47% |
| 3 Month Change | -70.38% |
| 1 Year Change | 44.21% |
| 33 Year Change | -12.18% |
| 5 Year Change | -20.81% |
| Change since IPO | -93.91% |
Recent News & Updates
Recent updates
Shareholder Returns
| E8X | DE Medical Equipment | DE Market | |
|---|---|---|---|
| 7D | 37.0% | -4.9% | -1.5% |
| 1Y | 44.2% | -5.6% | 7.9% |
Return vs Industry: E8X exceeded the German Medical Equipment industry which returned -4.2% over the past year.
Return vs Market: E8X exceeded the German Market which returned 8.3% over the past year.
Price Volatility
| E8X volatility | |
|---|---|
| E8X Average Weekly Movement | 37.7% |
| Medical Equipment Industry Average Movement | 5.8% |
| Market Average Movement | 4.8% |
| 10% most volatile stocks in DE Market | 11.0% |
| 10% least volatile stocks in DE Market | 2.4% |
Stable Share Price: E8X's share price has been volatile over the past 3 months compared to the German market.
Volatility Over Time: E8X's weekly volatility has decreased from 962% to 38% over the past year, but is still higher than 75% of German stocks.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 2002 | 9 | Xianlin Song | www.elexxion.com |
elexxion AG develops, produces, and sells dental lasers for soft and hard tissue applications primarily in Germany. The company offers dental diode lasers under the elexxion pico, elexxion nano, and elexxion claros names; and elexxion pico lite, a soft laser therapy. It also provides Odobleach; SNORE3 therapy; and perio green, a therapy product for the photothermal therapy of periodontology and periimplantitis, as well as repair services.
elexxion AG Fundamentals Summary
| E8X fundamental statistics | |
|---|---|
| Market cap | €3.03m |
| Earnings (TTM) | -€983.07k |
| Revenue (TTM) | €443.88k |
0.0x
P/S Ratio0.0x
P/E RatioIs E8X overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| E8X income statement (TTM) | |
|---|---|
| Revenue | €443.88k |
| Cost of Revenue | €385.34k |
| Gross Profit | €58.55k |
| Other Expenses | €1.04m |
| Earnings | -€983.07k |
Last Reported Earnings
Dec 31, 2022
Next Earnings Date
n/a
| Earnings per share (EPS) | 0 |
| Gross Margin | 0.00% |
| Net Profit Margin | 0.00% |
| Debt/Equity Ratio | 0.0% |
How did E8X perform over the long term?
See historical performance and comparison